Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Proteome Sciences plc (PRM) in Focus: What the Latest Developments Mean for the London Market

Proteome Sciences plc (PRM) is drawing attention because Investors are monitoring demand for proteomics services, biomarker programmes, laboratory capacity and whether research activity translates into repeat commercial revenue.

Ankur Sharma | 27 October 2026

Provexis Plc (PXS) in Focus: What the Latest Developments Mean for the London Market

Provexis Plc (PXS) is drawing attention because Attention remains on the commercial reach of Fruitflow, licensing arrangements, partner-led sales and the pace at which product adoption can create recurring income.

Ankur Sharma | 27 October 2026

Syncona’s Biotech Portfolio Hinges on Clinical Milestones and Funding Runway (LSE:SYNC)

Syncona is in focus as investors assess company-specific execution alongside broader conditions affecting the healthcare sector.

Ankur Sharma | 27 October 2026

Aptamer Group (LSE:APTA) teams up with Pharmahungary on Optimer delivery to heart and skeletal muscle

On Monday 26 October 2026, York-based Aptamer Group plc (LSE:APTA) announced a scientific collaboration with Pharmahungary Group, a biotech company developing microRNA (miRNA) therapeutics. The release was headlined "Optimer® collaboration targets heart and skeletal muscle". The aim is to generate preclinical data supporting future …

Ankur Sharma | 27 October 2026

Sareum (LSE:SAR) raises about £3.2m at 14p as AIM trading is restored and retail offer opens

On Monday 26 October 2026, Sareum Holdings plc (LSE:SAR), a clinical-stage biotechnology company developing kinase inhibitors for autoimmune disease and cancer, issued three linked announcements. The first set out a subscription to raise approximately £3.2 million before expenses. The second gave the terms of …

Ankur Sharma | 27 October 2026

One Health Group (LSE:OHGR) lifts half-year revenue 17% to £18.3m as NHS referrals jump 24%

One Health Group plc (LSE:OHGR), which provides NHS-funded elective surgery through the independent sector, published a trading update on 26 October 2026. It covers the six months to 30 September 2026, which the company calls H1 27. The company said the announcement contains inside …

Ankur Sharma | 27 October 2026

Bioventix (LSE:BVXP) holds 150p dividend as pre-tax profit edges up to £10.2m and Tau royalties treble

Bioventix plc (LSE:BVXP), which makes sheep monoclonal antibodies used in diagnostic blood tests, published results for the year ended 30 June 2026 on 26 October 2026. Revenue fell 0.8% to £13.0m, from £13.1m. The exact turnover figures were £12,971,744 and £13,115,869. At the average …

Ankur Sharma | 27 October 2026

NIOX Group’s Respiratory Diagnostics Story Hinges on Repeat Sales (LSE:NIOX)

The immediate question for investors is whether recent business developments can translate into measurable progress. For this company, the principal themes are feno-based respiratory diagnostics and asthma management; installed base, consumables revenue, clinical adoption and international growth. Investors typically look for evidence in formal …

Ankur Sharma | 27 October 2026

OptiBiotix Health: Can Partnerships Deliver More Visible Commercial Returns? (LSE:OPTI)

OptiBiotix Health plc is drawing attention as investors assess the next stage for a business focused on microbiome and health-related ingredients and technologies. For readers following the UK market, the relevant listing is LSE:OPTI. The central question on 27 October 2026 is whether upcoming …

Ankur Sharma | 27 October 2026

CRISM Therapeutics: Funding and Clinical Progress Shape the Next Phase (LSE:CRTX)

The immediate question for investors is whether recent business developments can translate into measurable progress. For this company, the principal themes are drug-delivery technology and clinical-stage development; october share issue, clinical milestones, partnerships and funding requirements. Investors typically look for evidence in formal company …

Ankur Sharma | 27 October 2026
Support

Hi! How can we help you today?

Loading…